Stock Screener App

無料 -

インストール

16.00

8.18% 1.21

Latigo Biotherapeutics, Inc. Common Stock (LTGO)

概要ニュース株価時系列 Financials ディスカッション予測

Latigo Biotherapeutics, Inc. Common Stock (LTGO) 最新ニュース

Latigo Biotherapeutics, Inc. Common Stock (NASDAQ: LTGO) Stock Price, News & Analysis - kalkine.ca

Latigo Biotherapeutics, Inc. Common Stock (LTGO) Earnings Reports & Dates - FXEmpire

Latigo Biotherapeutics Q2 Results: EPS loss narrows 24% YoY - scanx.trade

Latigo Biotherapeutics (LTGO) draws 4.45M-share stake from Deep Track - Stock Titan

Sanofi Converts Series B Preferred Stock and Convertible Note into Latigo Biotherapeutics Common Shares Following IPO - Kalkine Media

Latigo Biotherapeutics Completes IPO and Updates Governance - TipRanks

Latigo Biotherapeutics (LTGO) On IPO And Trial Data Looks About Right Valued - Yahoo Finance

Latigo Biotherapeutics (Nasdaq:LTGO)Stock Analysis - Simply Wall Street

Latigo Biotherapeutics Prices Upsized $345.6 Million Initial Public Offering - quiverquant.com

Latham & Watkins Advises on Latigo Biotherapeutics’ Upsized US$345.6 Million Initial Public Offering - Latham & Watkins LLP

Latigo Biotherapeutics Announces Pricing of Upsized $345.6 Million Initial Public Offering - GlobeNewswire

Latigo Biotherapeutics prices $345.6M IPO at $18 per share - Investing.com

Latigo Biotherapeutics files for Nasdaq IPO at up to $18 per share - Investing.com

Latigo Biotherapeutics files for $256M-$288M Nasdaq IPO - scanx.trade

Latigo Biotherapeutics Commences IPO Process For Pain Treatment Pipeline (Pending:LTGO) - Seeking Alpha

MRVI

$7.065

5.04%

IMTX

$7.20

3.10%

AVLN

$24.83

3.61%

JANX

$18.17

1.20%

MNKD

$3.12

5.17%

MGTX

$10.38

2.95%

Yahooで開く | Google で開く | Finviz で開く | マーケットウォッチで開く | エドガーでオープン | ロイターで開く